Press Releases

 
Select:
Mar 31, 2020
Elite Pharmaceuticals Announces Commercial Launch of Generic Adderall XR(R) with Marketing Partner Lannett Company

Feb 10, 2020
Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2020 Ended December 31, 2019 and Provides Conference Call Information

Feb 06, 2020
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2020 Financial Results on February 11, 2020

Dec 12, 2019
Elite Pharmaceuticals, Inc.: Elite Pharmaceuticals and SunGen Pharma Receive FDA Approval for Generic Adderall XR(R)

Nov 12, 2019
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2020 Ended September 30, 2019 and Provides Conference Call Information

Nov 06, 2019
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2020 Financial Results on November 13, 2019

Sep 12, 2019
Elite Pharmaceuticals Receives FDA Approval for Codeine and Acetaminophen Combo

Aug 11, 2019
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2020 Ended June 30, 2019 and Provides Conference Call Information

Aug 07, 2019
Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2020 Financial Results on August 12, 2019

Jun 28, 2019
Elite Pharmaceuticals Announces Commercial Launch of Dantrolene Capsules with Marketing Partner Lannett Company

 1     2    3   4   5   6   7